✦ LIBER ✦

Indirect Comparison of Tocilizumab and Other Biologic Agents in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs

✍ Scribed by Gert J.D. Bergman; Marc C. Hochberg; Maarten Boers; Neil Wintfeld; Adrian Kielhorn; Jeroen P. Jansen

Book ID: 113899958
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 595 KB
Volume: 39
Category: Article
ISSN: 0049-0172
DOI: 10.1016/j.semarthrit.2009.12.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interleukin-6 receptor inhibition with t

Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study

✍ Mark C. Genovese; James D. McKay; Evgeny L. Nasonov; Eduardo F. Mysler; Nilzio A 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

Efficacy of tocilizumab in patients with

Efficacy of tocilizumab in patients with moderate to severe active rheumatoid arthritis and a previous inadequate response to disease-modifying antirheumatic drugs: the ROSE study

✍ Yazici, Y.; Curtis, J. R.; Ince, A.; Baraf, H.; Malamet, R. L.; Teng, L. L.; Kav 📂 Article 📅 2011 🏛 BMJ Publishing Group 🌐 English ⚖ 301 KB

Indirect comparisons of the efficacy of

Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis

✍ Salliot, C.; Finckh, A.; Katchamart, W.; Lu, Y.; Sun, Y.; Bombardier, C.; Keysto 📂 Article 📅 2010 🏛 BMJ Publishing Group 🌐 English ⚖ 299 KB

Use of nonbiologic disease-modifying ant

Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis

✍ Lacaille, Diane ;Guh, Daphne P. ;Abrahamowicz, Michal ;Anis, Aslam H. ;Esdaile, 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

Comparison of effectiveness and safety o

Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs

✍ Mariangela Atteno; Rosario Peluso; Luisa Costa; Stefania Padula; Salvatore Iervo 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 108 KB

Newer disease-modifying antirheumatic dr

Newer disease-modifying antirheumatic drugs and the risk of serious hepatic adverse events in patients with rheumatoid arthritis

✍ Samy Suissa; Pierre Ernst; Marie Hudson; Alain Bitton; Abbas Kezouh 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 80 KB